NVAX Stock Analysis: Buy, Sell, or Hold?
NVAX - Novavax Inc
$10.11
0.88 (9.53%)
▲
5d:
+25.75%
30d:
+18.38%
90d:
+22.55%
HOLD
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Accumulation
NVAX is down 3.9% this week, but smart money is accumulating calls. Top strike: $9 2026-07-17 with 7,319 OI. Call ratio: 90% View Scanner →
Strength: 5.9/10
Get Alerted When NVAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
35 traders called NVAX this week
88% bullish • 6 bearish
88% bullish • 6 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: NVAX is 14.1% above its trading range ($8.86). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: NVAX is 14.1% above its trading range ($8.86). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: NVAX is currently trading at $10.11, which is considered extended relative to its 30-day fair value range of $7.85 to $8.86. From a valuation perspective, the stock is trading at a discount (Forward PE: -29.8) compared to its historical average (35.1). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, NVAX is in a uptrend. Immediate support is located at $7.71, while resistance sits at $10.75. The stock is showing strong short-term momentum, up 9.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+38.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NVAX is in a uptrend. Immediate support is located at $7.71, while resistance sits at $10.75. The stock is showing strong short-term momentum, up 9.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+38.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.85 -
$8.86
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.2%
Protect Your Profits
NVAX is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.1% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.5%)
- BULLISH: Trading 38.5% below Wall St target ($14.00)
Trading Range Analysis
30-Day Trading Range
$7.85 -
$8.86
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.71
Resistance Level
$10.75
Current Trend
Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-29.76
Wall Street Target
$14.00
(+38.5%)
Revenue Growth (YoY)
-79.1%
Earnings Growth (YoY)
-38.1%
Profit Margin
-14.7%
PE vs Historical
-29.8 vs 35.1
CHEAP
Share & Embed Analysis
Last updated: May 11, 2026 7:11 AM ET
Data refreshes hourly during market hours. Next update: 8:11 AM
Data refreshes hourly during market hours. Next update: 8:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 58 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 55 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 62 BUY |
Advanced NVAX Option Strategies
Professional options setups generated by AI based on today's NVAX price and gamma walls.
